Cargando…

Deltacron is a recombinant variant of SARS-CoV-2 but not a laboratory mistake

Detalles Bibliográficos
Autores principales:	Karbalaei, Mohsen, Keikha, Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212869/ https://www.ncbi.nlm.nih.gov/pubmed/35757314 http://dx.doi.org/10.1016/j.amsu.2022.104032

Ejemplares similares

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

The “Wolf” Is Indeed Coming: Recombinant “Deltacron” SARS-CoV-2 Detected
por: Wang, Liang, et al.
Publicado: (2022)

Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South Brazil
por: Sant’Anna, Fernando Hayashi, et al.
Publicado: (2023)

Probiotics and intestinal decolonization of antibiotic-resistant microorganisms; A reality or fantasy?
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

A close view of the Hepatitis C virus vaccines with further perspective
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Hospitalization records during monkeypox outbreaks: a scientific report from the available documents
por: Karbalaei, Mohsen, et al.
Publicado: (2023)

Deltacron: Apprehending a new phase of the COVID-19 pandemic
por: Maulud, Sazan Qadir, et al.
Publicado: (2022)

Epidemiological trends of Aedes-borne diseases in European countries during 2015–2020
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Chikungunya, zika, and dengue: Three neglected re-emerging Aedes-borne diseases
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Overlapping outbreak of COVID-19 and monkeypox in 2022: Warning for immediate preparedness in Iran
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Probiotic as anti-colorectal cancer agents: Challenges and further perspective
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Human monkeypox coinfections; lessons from available cases – Correspondence
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Cardiovascular disorders followed by SARS-CoV-2 infection: An inevitable challenge – Correspondence()
por: Rouhani, Jalil, et al.
Publicado: (2022)

Evidence of hantavirus circulation among the Iranian population: An emerging neglected tropical disease
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Ocular monkeypox as an emergency warning for ophthalmologists: a letter to editor
por: Karbalaei, Mohsen, et al.
Publicado: (2023)

Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations – Correspondence
por: Sahebi, Saeed, et al.
Publicado: (2022)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Multivalent vaccines against new SARS-CoV-2 hybrid variants
por: Ghazvini, Kiarash, et al.
Publicado: (2023)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection
por: Kurhade, Chaitanya, et al.
Publicado: (2022)

Clinical characteristics of human monkeypox laboratory confirmed cases: Lessons from observational studies
por: Sahebi, Saeed, et al.
Publicado: (2022)

High resolution melting assay as a reliable method for diagnosing drug-resistant TB cases: a systematic review and meta-analysis
por: Keikha, Masoud, et al.
Publicado: (2021)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Correlation between the geographical origin of Helicobacter pylori homB-positive strains and their clinical outcomes: a systematic review and meta-analysis
por: Keikha, Masoud, et al.
Publicado: (2021)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

The impact of SARS-CoV-2 variants on IBD management
por: Segal, Jonathan P, et al.
Publicado: (2021)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis
por: Keikha, Masoud, et al.
Publicado: (2022)

Antithetical Effects of MicroRNA Molecules in Tuberculosis Pathogenesis
por: Keikha, Masoud, et al.
Publicado: (2019)

Overview on coinfection of HTLV-1 and tuberculosis: Mini-review
por: Keikha, Masoud, et al.
Publicado: (2021)

Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections
por: Keikha, Masoud, et al.
Publicado: (2021)

Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

Delineating the Spread and Prevalence of SARS-CoV-2 Omicron Sublineages (BA.1–BA.5) and Deltacron Using Wastewater in the Western Cape, South Africa( )
por: Johnson, Rabia, et al.
Publicado: (2022)

Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics
por: Dwibedi, Bhagirathi
Publicado: (2020)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mgshiag82rp4fpt7gpd58egrv7